These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24924840)

  • 1. Effects of metabolic syndrome, apolipoprotein E, and CYP46 on cognition among Taiwanese Chinese.
    Lai CL; Liou LM; Liu CK; Yang YH; Lin RT
    Kaohsiung J Med Sci; 2014 Jul; 30(7):343-9. PubMed ID: 24924840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
    Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
    Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholesterol and CYP46 polymorphism on cognitive event-related potentials.
    Lai CL; Hsu CY; Liou LM; Hsieh HY; Hsieh YH; Liu CK
    Psychophysiology; 2011 Nov; 48(11):1572-1577. PubMed ID: 21729100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.
    Wang B; Zhang C; Zheng W; Lu Z; Zheng C; Yang Z; Wang L; Jin F
    Neurosci Lett; 2004 Oct; 369(2):104-7. PubMed ID: 15450677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP46: a risk factor for Alzheimer's disease or a coincidence?
    Golanska E; Hulas-Bigoszewska K; Wojcik I; Rieske P; Styczynska M; Peplonska B; Pfeffer A; Luczywek E; Wasiak B; Gabryelewicz T; Religa D; Chodakowska-Zebrowska M; Barcikowska M; Sobow T; Liberski PP
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):105-8. PubMed ID: 15936520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.
    Tedde A; Rotondi M; Cellini E; Bagnoli S; Muratore L; Nacmias B; Sorbi S
    Neurobiol Aging; 2006 May; 27(5):773.e1-773.e3. PubMed ID: 16055229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.
    Desai P; DeKosky ST; Kamboh MI
    Neurosci Lett; 2002 Aug; 328(1):9-12. PubMed ID: 12123847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
    Golanska E; Hulas-Bigoszewska K; Sieruta M; Zawlik I; Witusik M; Gresner SM; Sobow T; Styczynska M; Peplonska B; Barcikowska M; Liberski PP; Corder EH
    J Alzheimers Dis; 2009; 17(2):359-68. PubMed ID: 19363267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
    Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
    Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
    Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association of CYP46 and risk for Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Berciano J
    Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.
    Burkhardt MS; Foster JK; Clarnette RM; Chubb SA; Bruce DG; Drummond PD; Martins RN; Yeap BB
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1168-72. PubMed ID: 16368754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese.
    Wang F; Jia J
    Brain Res; 2007 May; 1147():34-8. PubMed ID: 17335784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.
    Helisalmi S; Vepsäläinen S; Koivisto AM; Mannermaa A; Iivonen S; Hiltunen M; Kiviniemi V; Soininen H
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):421-2. PubMed ID: 16484661
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
    Chalmers KA; Culpan D; Kehoe PG; Wilcock GK; Hughes A; Love S
    Neuroreport; 2004 Jan; 15(1):95-8. PubMed ID: 15106838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.